Variant report
Variant | esv2762459 |
---|---|
Chromosome Location | chr4:118850266-118869209 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199909550 | chr4:118861206-118861207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566713212 | chr4:118861216-118861217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9884363 | chr4:118861217-118861218 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs201879401 | chr4:118861222-118861223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373394101 | chr4:118861255-118861256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569273320 | chr4:118861287-118861288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537926034 | chr4:118861290-118861291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557964222 | chr4:118861305-118861306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112540409 | chr4:118861312-118861313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190409626 | chr4:118861319-118861320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533010917 | chr4:118861362-118861363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182114460 | chr4:118861366-118861367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554044927 | chr4:118861376-118861377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573362195 | chr4:118861383-118861384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574231324 | chr4:118861419-118861420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141900197 | chr4:118861426-118861427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150764579 | chr4:118861461-118861462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138036831 | chr4:118861532-118861533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575280309 | chr4:118861540-118861541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544317247 | chr4:118861566-118861567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564323169 | chr4:118861594-118861595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533164583 | chr4:118861647-118861648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540389994 | chr4:118861664-118861665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560204127 | chr4:118861710-118861711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529160334 | chr4:118861713-118861714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186810461 | chr4:118861759-118861760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373934238 | chr4:118861801-118861802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192102785 | chr4:118861802-118861803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375110795 | chr4:118861816-118861817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76103569 | chr4:118861869-118861870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76613971 | chr4:118861961-118861962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571357790 | chr4:118861975-118861976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540319994 | chr4:118862025-118862026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559927595 | chr4:118862034-118862035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183927746 | chr4:118862037-118862038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186760729 | chr4:118862055-118862056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190044306 | chr4:118862063-118862064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139801175 | chr4:118862098-118862099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550934171 | chr4:118862134-118862135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555111249 | chr4:118862161-118862162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575311289 | chr4:118862197-118862198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537797366 | chr4:118862200-118862201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557896030 | chr4:118862203-118862204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577779802 | chr4:118862209-118862210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182607317 | chr4:118862238-118862239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111297690 | chr4:118862398-118862399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528860784 | chr4:118862445-118862446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369271002 | chr4:118862474-118862475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187308154 | chr4:118862477-118862478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143201497 | chr4:118862481-118862482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:118861200-118862800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:118862400-118863000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr4:118862400-118863200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr4:118862400-118863200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr4:118862400-118863400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr4:118862600-118863200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr4:118862600-118863200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr4:118862600-118863400 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr4:118862600-118863400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr4:118862600-118863400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr4:118862600-118863400 | Enhancers | Dnd41 | blood |
12 | chr4:118862800-118863400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr4:118862800-118863400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr4:118863000-118863200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |